Literature DB >> 21525357

Ambivalent role of the innate immune response in rabies virus pathogenesis.

Damien Chopy1, Julien Pothlichet, Mireille Lafage, Françoise Mégret, Laurence Fiette, Mustapha Si-Tahar, Monique Lafon.   

Abstract

The neurotropic rabies virus (RABV) has developed several evasive strategies, including immunoevasion, to successfully infect the nervous system (NS) and trigger a fatal encephalomyelitis. Here we show that expression of LGP2, a protein known as either a positive or negative regulator of the RIG-I-mediated innate immune response, is restricted in the NS. We used a new transgenic mouse model (LGP2 TG) overexpressing LGP2 to impair the innate immune response to RABV and thus revealed the role of the RIG-I-mediated innate immune response in RABV pathogenesis. After infection, LGP2 TG mice exhibited reduced expression of inflammatory/chemoattractive molecules, beta interferon (IFN-β), and IFN-stimulated genes in their NS compared to wild-type (WT) mice, demonstrating the inhibitory function of LGP2 in the innate immune response to RABV. Surprisingly, LGP2 TG mice showed more viral clearance in the brain and lower morbidity than WT mice, indicating that the host innate immune response, paradoxically, favors RABV neuroinvasiveness and morbidity. LGP2 TG mice exhibited similar neutralizing antibodies and microglia activation to those of WT mice but showed a reduction of infiltrating CD4(+) T cells and less disappearance of infiltrating CD8(+) T cells. This occurred concomitantly with reduced neural expression of the IFN-inducible protein B7-H1, an immunoevasive protein involved in the elimination of infiltrated CD8(+) T cells. Our study shows that the host innate immune response favors the infiltration of T cells and, at the same time, promotes CD8(+) T cell elimination. Thus, to a certain extent, RABV exploits the innate immune response to develop its immunoevasive strategy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21525357      PMCID: PMC3126514          DOI: 10.1128/JVI.00302-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  59 in total

Review 1.  The immune response to rabies virus infection and vaccination.

Authors:  Nicholas Johnson; Adam F Cunningham; Anthony R Fooks
Journal:  Vaccine       Date:  2010-04-03       Impact factor: 3.641

2.  Production of monoclonal antibodies against the Pasteur (P.V.) strain of rabies virus: problems and results.

Authors:  G Libeau; M Lafon
Journal:  Dev Biol Stand       Date:  1984

3.  A rapid tissue culture test for determining rabies neutralizing antibody.

Authors:  J S Smith; P A Yager; G M Baer
Journal:  Monogr Ser World Health Organ       Date:  1973

4.  Role of interferon antagonist activity of rabies virus phosphoprotein in viral pathogenicity.

Authors:  Naoto Ito; Gregory W Moseley; Danielle Blondel; Kenta Shimizu; Caitlin L Rowe; Yuki Ito; Tatsunori Masatani; Keisuke Nakagawa; David A Jans; Makoto Sugiyama
Journal:  J Virol       Date:  2010-04-28       Impact factor: 5.103

5.  Rabies virus nucleoprotein functions to evade activation of the RIG-I-mediated antiviral response.

Authors:  Tatsunori Masatani; Naoto Ito; Kenta Shimizu; Yuki Ito; Keisuke Nakagawa; Yoshiharu Sawaki; Hiroyuki Koyama; Makoto Sugiyama
Journal:  J Virol       Date:  2010-02-03       Impact factor: 5.103

6.  IPS-1 is essential for the control of West Nile virus infection and immunity.

Authors:  Mehul S Suthar; Daphne Y Ma; Sunil Thomas; Jennifer M Lund; Nu Zhang; Stephane Daffis; Alexander Y Rudensky; Michael J Bevan; Edward A Clark; Murali-Krishna Kaja; Michael S Diamond; Michael Gale
Journal:  PLoS Pathog       Date:  2010-02-05       Impact factor: 6.823

Review 7.  B7-H1 pathway and its role in the evasion of tumor immunity.

Authors:  Haidong Dong; Lieping Chen
Journal:  J Mol Med (Berl)       Date:  2003-04-30       Impact factor: 4.599

8.  Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis.

Authors:  Bettina Schreiner; Meike Mitsdoerffer; Bernd C Kieseier; Lieping Chen; Hans-Peter Hartung; Michael Weller; Heinz Wiendl
Journal:  J Neuroimmunol       Date:  2004-10       Impact factor: 3.478

9.  Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion.

Authors:  Haidong Dong; Scott E Strome; Diva R Salomao; Hideto Tamura; Fumiya Hirano; Dallas B Flies; Patrick C Roche; Jun Lu; Gefeng Zhu; Koji Tamada; Vanda A Lennon; Esteban Celis; Lieping Chen
Journal:  Nat Med       Date:  2002-06-24       Impact factor: 53.440

10.  Rabies virus glycoprotein. II. Biological and serological characterization.

Authors:  J H Cox; B Dietzschold; L G Schneider
Journal:  Infect Immun       Date:  1977-06       Impact factor: 3.441

View more
  17 in total

1.  The type I interferon response bridles rabies virus infection and reduces pathogenicity.

Authors:  Damien Chopy; Claudia N Detje; Mireille Lafage; Ulrich Kalinke; Monique Lafon
Journal:  J Neurovirol       Date:  2011-07-30       Impact factor: 2.643

2.  Inhibition of MALT1 Decreases Neuroinflammation and Pathogenicity of Virulent Rabies Virus in Mice.

Authors:  S Van Gucht; R Beyaert; E Kip; J Staal; H G Tima; L Verstrepen; M Romano; K Lemeire; V Suin; A Hamouda; M Baens; C Libert; M Kalai
Journal:  J Virol       Date:  2018-10-29       Impact factor: 5.103

3.  Postexposure treatment with the live-attenuated rabies virus (RV) vaccine TriGAS triggers the clearance of wild-type RV from the Central Nervous System (CNS) through the rapid induction of genes relevant to adaptive immunity in CNS tissues.

Authors:  Jianwei Li; Adam Ertel; Carla Portocarrero; Darryll A Barkhouse; Bernhard Dietzschold; D Craig Hooper; Milosz Faber
Journal:  J Virol       Date:  2012-01-11       Impact factor: 5.103

4.  Expression of interferon gamma by a recombinant rabies virus strongly attenuates the pathogenicity of the virus via induction of type I interferon.

Authors:  Darryll A Barkhouse; Samantha A Garcia; Emily K Bongiorno; Aurore Lebrun; Milosz Faber; D Craig Hooper
Journal:  J Virol       Date:  2014-10-15       Impact factor: 5.103

5.  Plasma Non-transferrin-Bound Iron Could Enter into Mice Duodenum and Negatively Affect Duodenal Defense Response to Virus and Immune Responses.

Authors:  Xiaonan Yu; Qian Zhang; Haoxuan Ding; Peng Wang; Jie Feng
Journal:  Biol Trace Elem Res       Date:  2022-03-16       Impact factor: 3.738

6.  Anti-lyssaviral activity of interferons κ and ω from the serotine bat, Eptesicus serotinus.

Authors:  Xiaocui He; Tomaš Korytař; Juliane Schatz; Conrad M Freuling; Thomas Müller; Bernd Köllner
Journal:  J Virol       Date:  2014-02-26       Impact factor: 5.103

7.  Rabies virus infection in Eptesicus fuscus bats born in captivity (naïve bats).

Authors:  April D Davis; Jodie A Jarvis; Craig Pouliott; Robert J Rudd
Journal:  PLoS One       Date:  2013-05-31       Impact factor: 3.240

8.  Passive carriage of rabies virus by dendritic cells.

Authors:  Kazuyo Senba; Takashi Matsumoto; Kentaro Yamada; Seiji Shiota; Hidekatsu Iha; Yukari Date; Motoaki Ohtsubo; Akira Nishizono
Journal:  Springerplus       Date:  2013-08-29

9.  Incorporation of membrane-anchored flagellin or Escherichia coli heat-labile enterotoxin B subunit enhances the immunogenicity of rabies virus-like particles in mice and dogs.

Authors:  Yinglin Qi; Hongtao Kang; Xuexing Zheng; Hualei Wang; Yuwei Gao; Songtao Yang; Xianzhu Xia
Journal:  Front Microbiol       Date:  2015-03-03       Impact factor: 5.640

10.  Genome-Wide Transcriptional Profiling Reveals Two Distinct Outcomes in Central Nervous System Infections of Rabies Virus.

Authors:  Daiting Zhang; Feilong He; Shuilian Bi; Huixia Guo; Baoshi Zhang; Fan Wu; Jiaqi Liang; Youtian Yang; Qin Tian; Chunmei Ju; Huiying Fan; Jinding Chen; Xiaofeng Guo; Yongwen Luo
Journal:  Front Microbiol       Date:  2016-05-19       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.